| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/09/2009 | CA2296727C Pyrazine derivatives, preparation and medicines containing them |
| 06/04/2009 | WO2009070378A1 Compositions and methods for inhibiting the activation of dsrna-dependent protein kinase and tumor growth inhibition |
| 06/04/2009 | WO2009070314A2 Crystalline form of sitagliptin |
| 06/04/2009 | WO2009070130A1 The 1,3-disubstituted ureas, method of re aration and utilisation thereof |
| 06/04/2009 | WO2009070080A1 New insulin for diabetics on persons with overweight |
| 06/04/2009 | WO2009069992A1 Composition comprising extracts of soy, rice, sesame and indian fig for a food supplement |
| 06/04/2009 | WO2009069983A2 A pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugate |
| 06/04/2009 | WO2009069736A1 Nitrogenated compound |
| 06/04/2009 | WO2009069546A1 Therapeutic or prophylactic agent, detection method and detection agent for metabolic syndrome, and method for screening of candidate compound for therapeutic agent for metabolic syndrome |
| 06/04/2009 | WO2009068468A2 Pyridine compounds |
| 06/04/2009 | WO2009068246A2 Methods of treating obesity and metabolic disorders |
| 06/04/2009 | WO2009051786A3 Methods for treating obesity, insulin resistance and inducing satiety |
| 06/04/2009 | WO2009047798A3 Acetamide derivatives as glucokinase activators, their process and medicinal applications |
| 06/04/2009 | WO2009040022A3 Use of a peptide as a therapeutic agent |
| 06/04/2009 | WO2009033815A3 Use of the peptide combination ala-pro-gly-pro-arg with cecropin a as a therapeutic agent |
| 06/04/2009 | WO2009033734A3 Use of a peptide as a therapeutic agent |
| 06/04/2009 | WO2009027753A4 Composition and method inhibiting inflammation |
| 06/04/2009 | WO2008157635A3 Synthetic bile acid composition, method, and preparation |
| 06/04/2009 | US20090143763 Rotatable infusion set |
| 06/04/2009 | US20090143571 Novel genes and their use in the modulation of obesity, diabetes and energy imbalance |
| 06/04/2009 | US20090143469 Salts of nateglinide |
| 06/04/2009 | US20090143462 Products of Tetrahydrocannabinol, Compositions Comprising Prodrugs of Tetrahydrocannabinol and Methods of Using the Same |
| 06/04/2009 | US20090143459 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 06/04/2009 | US20090143445 HDAC Inhibitors |
| 06/04/2009 | US20090143396 Sulfonyl-Substituted Aryl Compounds as Modulators of Peroxisome Proliferator Activated Receptors |
| 06/04/2009 | US20090143392 Methods of Treating Obesity and Metabolic Disorders |
| 06/04/2009 | US20090143391 Aryl and heteroaryl fused imidazo [1,5-a] pyrazines as inhibitors of phosphodiesterase 10 |
| 06/04/2009 | US20090143390 Parenteral Formulations of Dopamine Agonists |
| 06/04/2009 | US20090143386 Human adam-10 inhibitors |
| 06/04/2009 | US20090143376 Fused Heterocyclic Compounds and Their Use as Sirtuin Modulators |
| 06/04/2009 | US20090143374 Use of Compounds and Compositions for the Treatment of Amyloid Diseases |
| 06/04/2009 | US20090143372 Chemical compounds |
| 06/04/2009 | US20090143361 Pyrido[3,2-E]Pyrazines, Process For Preparing The Same, And Their Use As Inhibitors Of Phosphodiesterase 10 |
| 06/04/2009 | US20090143342 26,27-homologated-20-EPI-2-alkylidene-19-nor-vitamin D compounds |
| 06/04/2009 | US20090143316 Cocrystal of c-glycoside derivative and l-proline |
| 06/04/2009 | US20090143309 converting an agonist of protein kinase C to an antagonist of protein kinase C; amino acid sequences; crosslinked via an N-terminal Cys-Cys bond to a peptide to facilitate transport cellular uptake |
| 06/04/2009 | US20090143283 Pituitary Adenylate Cyclase Activating Peptide (PACAP) Receptor (VPAC2) Agonists and Their Pharmacological Methods of Use |
| 06/04/2009 | US20090143279 Methods and compositions for treating metabolic disorders |
| 06/04/2009 | US20090143277 Nutritional composition for controlling blood sugar level |
| 06/04/2009 | US20090143275 Adiponectin receptor fragments and methods of use |
| 06/04/2009 | US20090142831 Placental stem cells |
| 06/04/2009 | US20090142782 Using actinobacillus specific immunogolbulins to diagnose gum disease |
| 06/04/2009 | US20090142428 Extracts from the Bark of Corynanthe Species and Use Thereof as Well as Medicaments, Dietetic Food Products and Pharmaceutical Preparations Containing Said Extracts |
| 06/04/2009 | US20090142425 Physiologically active composition |
| 06/04/2009 | US20090142360 Use of ferritin to treat iron deficiency disorders |
| 06/04/2009 | US20090142351 Human and rat PGC-3, PPAR-gamma coactivations and splice variants thereof |
| 06/04/2009 | US20090142338 Methods and Compositions for Treating Type 1 and Type 2 Diabetes Mellitus and Related Conditions |
| 06/04/2009 | US20090142335 Methods of diagnosis and treatment of metabolic disorders |
| 06/04/2009 | US20090142323 Methods for treating a disorder by regulating gprc6a |
| 06/04/2009 | US20090142321 Opthalmic composition |
| 06/04/2009 | US20090142308 Methods for treating autoimmune disease by inducing autoantigen-specific regulatory CD4+ T cells |
| 06/04/2009 | US20090142298 Apolactoferrin Compositions and Methods for Their Use in the Treatment of Viral Hepatitis C |
| 06/04/2009 | US20090142296 Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue |
| 06/04/2009 | CA2706656A1 Compositions and methods for inhibiting the activation of dsrna-dependent protein kinase and tumor growth inhibition |
| 06/04/2009 | CA2706627A1 A pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugate |
| 06/04/2009 | CA2706576A1 Pyridine compounds |
| 06/04/2009 | CA2704493A1 Organic compounds |
| 06/03/2009 | EP2065467A2 Anti-interferon-alpha antibodies |
| 06/03/2009 | EP2065401A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 06/03/2009 | EP2065400A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 06/03/2009 | EP2065366A2 HIF hydroxylase inhibitors |
| 06/03/2009 | EP2065053A1 Cell death inhibitor |
| 06/03/2009 | EP2065044A1 Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators |
| 06/03/2009 | EP2065041A1 Use of medium chain triglycerides for the treatment and prevention of Parkinson's disease, Huntington' disease or Amyloid Lateral Sclerosis resulting from reduced neuronal metabolism |
| 06/03/2009 | EP2064193A1 Heterocyclic gpr40 modulators |
| 06/03/2009 | EP2064182A1 4-piperidylbenzamides as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors |
| 06/03/2009 | EP2063962A2 Irak modulators for treating an inflammatory condition, cell proliferative disorder, immune disorder |
| 06/03/2009 | EP2063890A1 Combination treatment for diabetes mellitus |
| 06/03/2009 | EP1910310B1 Novelimidazolecarboxamide derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same |
| 06/03/2009 | EP1667679B1 Aminobenzimidazoles as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 06/03/2009 | EP1660077B1 Indol-6 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 06/03/2009 | EP1648446B1 Indol-4 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 06/03/2009 | EP1648445B1 Indol-5-yl sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 06/03/2009 | EP1648444B1 Indol-7 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 06/03/2009 | EP1399440B1 5-(2-aminopyrimidin-4-yl)benzisoxazoles as protein kinase inhibitors |
| 06/03/2009 | EP1263720B1 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same |
| 06/03/2009 | EP1218544B1 TAR RNA binding peptides |
| 06/03/2009 | EP1140079B1 Assays for ligands for nuclear receptors |
| 06/03/2009 | CN101445463A Beta2-adrenergic receptor agonists |
| 06/03/2009 | CN101444509A Triple monoamine reuptake inhibitors for the treatment of chronic pain |
| 06/03/2009 | CN101444498A Use of retigabine or its medical salts for the treatment of neuropathic pain |
| 06/03/2009 | CN101444496A Compounds for the treatment of metabolic disorders |
| 06/03/2009 | CN100494190C Compound containing o-naphthaquinone and application |
| 06/03/2009 | CN100494185C Novel quaternary ammonium compounds |
| 06/03/2009 | CN100494182C Regulatory factor of tumor necrosis alpha factor |
| 06/03/2009 | CN100494175C Solvates of lercanidipine hydrochloride and new crystalline forms of lercanidipine hydrochloride |
| 06/03/2009 | CN100493617C Recombinant adeno-associated virus for prevention and cure of I-type diabetes and use thereof |
| 06/03/2009 | CN100493568C Rhizome Anemarrhenae total saponin and its preparation method |
| 06/03/2009 | CN100493531C Chinese medicine for treating diabetes |
| 06/02/2009 | US7541477 hormone inhibitor 5-(4-fluorophenyl)-N-{2-[isopropyl(methyl)amino]-1H-benzimidazol-6-yl}-2-pyridinecarboxamide; treating the disorders of cardiovascular system, nervous system, metabolic systems, reproductive system, respiratory system, digestive system |
| 06/02/2009 | US7541375 Azole derivatives and pharmaceutical compositions containing them |
| 06/02/2009 | US7541373 2-[3-(2-cyclopentanecarbonyl-4-methyl-phenyl)-ureido]-thiazol-4-yl} acetic acid; 2-[3-(4-Methyl-2-[2-methylpropoxy] phenyl)-ureido]-thiazol-4-yl}-acetic acid; activators of glucokinase; treatment of metabolic disorders, hyperglycemic agent, syndrome x, anticholesterol, hypertension etc. |
| 06/02/2009 | US7541369 Amino-derivatives as novel inhibitors of histone deacetylase |
| 06/02/2009 | US7541362 7-(3,4-Dichlorophenyl)-4,7-dihydro-5-methyl-6-(5-phenyl-2-oxazolyl)pyrazolo[1, 5-a]pyrimidine |
| 06/02/2009 | US7541361 N-[4,5-diphenylpyrimidin-2-yl)methyl]amine derivatives, the preparation thereof and their therapeutic use |
| 06/02/2009 | US7541341 2-(4-ethylbenzyl)-5-hydroxymethylphenyl 6-O-ethoxycarbonyl- beta -D-glucopyranoside; for treatment/prevention of hyperglycemia associated with diabetes/obesity |
| 06/02/2009 | US7541329 Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease |
| 06/02/2009 | US7541154 GASP1: a follistatin domain containing protein |
| 06/02/2009 | US7541031 Methods for treating rheumatoid arthritis using human antibodies that bind human TNFα |
| 06/02/2009 | US7541024 A stable polyallylamine hydrochloride polymer crosslinked by epichlorohydrin |